400 FAQs on Good Clinical Practice Interpretation and Implementation of Good Clinical Practice In Drug Trials
Posted on: Thursday, 30 March 2006, 06:00 CST
Recommended reading for new recruits to the pharmaceutical business this month is Good Clinical Practice, a pocket guide to Good Clinical Practice requirements in drug, biologics and device clinical trials. The pocket book guide is presented in question and answer format and covers 400 frequently asked questions about the conduct of clinical trials. The recommendation comes from online pharma business bookshop, Piribo Ltd.
In the wake of the unprecedented adverse reactions experienced by all six triallists given the new TeGenero investigational drug this month, there has inevitably been considerable conjecture about the causes of the events in this trial. This book is an accessible introduction to the regulations governing clinical trials.
There are over 60 companies currently engaged in the development of drugs based on monoclonal antibodies, which was the class of drug involved in this trial. Six lead drugs are in Phase III and six in Phase II. Further titles of possible interest to R&D scientists who might want to update on clinical trials in this area is New Directions in Monoclonal Antibodies, and for the latest strategies using conjugated or chimeric MAbs as anticancer therapies, there is Improved Monoclonals On The Rise, one of nearly 100 books and industry reports available form Piribo on the subject.
Good Clinical Practice, price GBP 23 is available from Piribo at www.piribo.com
Note to editors:
Piribo Ltd
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries 3,500 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest.
The company was established in 2004.
www.piribo.com.
Source: Business Wire
Related Articles
- GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate
- Fertility Centers of Illinois Seeks In Vitro Fertilization Patients for Clinical Trial of Investigational Drug That Promotes Pregnancy
- Array BioPharma Initiates Clinical Trials of Cancer Drug
- Potentia Commences Clinical Trials for AMD Drug
- Transition Gets Go-Ahead for Clinical Trials of Alzheimer's Drug
- Can-Fite on Its Way to Initiate Clinical Trials With Second Drug - CF102; Company Initiated Non-Clinical Development of the Drug
- Doctors Say Clinical Trial of Bird Flu Vaccine a Good First Step
- Eisai to Hold Clinical Trials for Diabetes Drug
- Celera Genomics of Rockville Begins Phase 1 Clinical Trial for Psoriasis Drug
- Approval of Clofarabine for Treating Leukemia Highlights Importance of Offering Children Access to Clinical Trials of New Drugs
 |
 |
User Comments (0)
RSS Feeds